Cargando…

Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET

Electroconvulsive therapy (ECT) is a potent therapy in severe treatment-refractory depression. Although commonly applied in psychiatric clinical routine since decades, the exact neurobiological mechanism regarding its efficacy remains unclear. Results from preclinical and clinical studies emphasize...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanzenberger, R, Baldinger, P, Hahn, A, Ungersboeck, J, Mitterhauser, M, Winkler, D, Micskei, Z, Stein, P, Karanikas, G, Wadsak, W, Kasper, S, Frey, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526726/ https://www.ncbi.nlm.nih.gov/pubmed/22751491 http://dx.doi.org/10.1038/mp.2012.93

Ejemplares similares

PS183. Effect of electroconvulsive therapy on monoamine oxidase A binding - a preliminary report
por: Baldinger-Melich, Pia, et al.
Publicado: (2016)

The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning
por: Kautzky, A, et al.
Publicado: (2017)

Effects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression
por: James, Gregory M., et al.
Publicado: (2017)

Exploring the Impact of BDNF Val66Met Genotype on Serotonin Transporter and Serotonin-1A Receptor Binding
por: Kraus, Christoph, et al.
Publicado: (2014)

Effects of Silexan on the Serotonin-1A Receptor and Microstructure of the Human Brain: A Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study with Molecular and Structural Neuroimaging
por: Baldinger, Pia, et al.
Publicado: (2015)

High-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People
por: Kranz, Georg S., et al.
Publicado: (2015)

PS186. Light exposure and seasonal variation of the serotonin degrading enzyme monoamine oxidase A in the healthy human brain revealed by PET
por: Hienert, Marius, et al.
Publicado: (2016)

[(18)F]FE@SNAP—A new PET tracer for the melanin concentrating hormone receptor 1 (MCHR1): Microfluidic and vessel-based approaches
por: Philippe, Cécile, et al.
Publicado: (2012)

PS168. Hybrid PET/MR imaging of serotonin transporter occupancy and brain activation to elucidate the mechanism of action of selective serotonin reuptake inhibitors
por: Gryglewski, G, et al.
Publicado: (2016)

Attenuation Correction Approaches for Serotonin Transporter Quantification With PET/MRI
por: Rischka, Lucas, et al.
Publicado: (2019)

Reliable set-up for in-loop (11)C-carboxylations using Grignard reactions for the preparation of [carbonyl-(11)C]WAY-100635 and [(11)C]-(+)-PHNO()
por: Rami-Mark, Christina, et al.
Publicado: (2013)

Changes in White Matter Microstructure After Electroconvulsive Therapy for Treatment-Resistant Depression
por: Gryglewski, Gregor, et al.
Publicado: (2019)

Serotonin Transporter Binding in the Human Brain After Pharmacological Challenge Measured Using PET and PET/MR
por: Silberbauer, Leo R., et al.
Publicado: (2019)

Radiosynthesis of [(11)C]SNAP-7941—the first PET-tracer for the melanin concentrating hormone receptor 1 (MCHR1)
por: Philippe, C., et al.
Publicado: (2012)

Brain glucose uptake during transcranial direct current stimulation measured with functional [(18)F]FDG-PET
por: Kraus, Christoph, et al.
Publicado: (2019)

Preparation and First Preclinical Evaluation of [(18)F]FE@SNAP: A Potential PET Tracer for the Melanin-Concentrating Hormone Receptor-1 (MCHR1)
por: Philippe, Cécile, et al.
Publicado: (2013)

Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Correction: Epistasis of HTR1A and BDNF risk genes alters cortical 5-HT1A receptor binding: PET results link genotype to molecular phenotype in depression
por: Kautzky, Alexander, et al.
Publicado: (2019)

Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain
por: Komorowski, A., et al.
Publicado: (2017)

Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis
por: Gryglewski, Gregor, et al.
Publicado: (2019)

A PET microdosing study with the P-glycoprotein inhibitor tariquidar
por: Bauer, Martin, et al.
Publicado: (2012)

[(11)C]acetate PET as a tool for diagnosis of liver steatosis
por: Nejabat, Marzieh, et al.
Publicado: (2018)

Topologically Guided Prioritization of Candidate Gene Transcripts Coexpressed with the 5-HT(1A) Receptor by Combining In Vivo PET and Allen Human Brain Atlas Data
por: Unterholzner, Jakob, et al.
Publicado: (2020)

Task-relevant brain networks identified with simultaneous PET/MR imaging of metabolism and connectivity
por: Hahn, Andreas, et al.
Publicado: (2017)

Machine learning classification of ADHD and HC by multimodal serotonergic data
por: Kautzky, A., et al.
Publicado: (2020)

PS189. Post-transcriptional processes in the main serotonin degrading enzyme MAO-A in the adult human brain investigated in vivo with PET and postmortem data
por: Komorowski, A, et al.
Publicado: (2016)

Repetitive enhancement of serum BDNF subsequent to continuation ECT
por: Vanicek, T., et al.
Publicado: (2019)

Association of dopamine D(2/3) receptor binding potential measured using PET and [(11)C]-(+)-PHNO with post-mortem DRD(2/3) gene expression in the human brain
por: Komorowski, Arkadiusz, et al.
Publicado: (2020)

PT550. Interregional Correlations of SERT in Attention Deficit/Hyperactivity Disorder compared to Healthy Controls; Investigated with PET and [(11)C]DASB
por: Vanicek, Thomas, et al.
Publicado: (2016)

Radiosynthesis and first preclinical evaluation of the novel norepinephrine transporter pet-ligand [(11)C]ME@HAPTHI
por: Rami-Mark, Christina, et al.
Publicado: (2015)

Parcellation of the Human Cerebral Cortex Based on Molecular Targets in the Serotonin System Quantified by Positron Emission Tomography In vivo
por: James, Gregory M, et al.
Publicado: (2019)

Effects of bilateral sequential theta-burst stimulation on 5-HT(1A) receptors in the dorsolateral prefrontal cortex in treatment-resistant depression: a proof-of-concept trial
por: Murgaš, Matej, et al.
Publicado: (2023)

Parameter evaluation and fully-automated radiosynthesis of [(11)C]harmine for imaging of MAO-A for clinical trials
por: Philippe, C., et al.
Publicado: (2015)

Meta-analysis of molecular imaging of serotonin transporters in major depression
por: Gryglewski, Gregor, et al.
Publicado: (2014)

ABCB1 variants and sex affect serotonin transporter occupancy in the brain
por: Silberbauer, Leo R., et al.
Publicado: (2022)

Effects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PET
por: Sigurdardottir, Helen L., et al.
Publicado: (2015)

Reliability of task-specific neuronal activation assessed with functional PET, ASL and BOLD imaging
por: Rischka, Lucas, et al.
Publicado: (2021)

Assessment of Ketamine Binding of the Serotonin Transporter in Humans with Positron Emission Tomography
por: Spies, Marie, et al.
Publicado: (2017)

Association of norepinephrine transporter methylation with in vivo NET expression and hyperactivity–impulsivity symptoms in ADHD measured with PET
por: Sigurdardottir, H. L., et al.
Publicado: (2019)

Impact of genetic variants within serotonin turnover enzymes on human cerebral monoamine oxidase A in vivo
por: Spies, Marie, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0j48879tsdiurt60979n114tcf